✦ LIBER ✦

Erratum: Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

✍ Scribed by Delphine Allard; Sabine Amsellem; Marianne Abifadel; Mélanie Trillard; Martine Devillers; Gérald Luc; Michel Krempf; Yves Reznik; Jean-Philippe Girardet; Alexandre Fredenrich; Claudine Junien; Mathilde Varret; Catherine Boileau; Pascale Benlian; Jean-Pierre Rabès

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 18 KB
Volume: 26
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9386

No coin nor oath required. For personal study only.

✦ Synopsis

The original article to which this Erratum refers was published in Human Mutation 26: 497 (2005) In Table 2, the first footnote that reads "*Associated with p.D347Y on the same allele." should read "*Associated with p.D347Y." as it is not known if the two mutations are in cis or in trans.

📜 SIMILAR VOLUMES

Novel mutations of the PCSK9 gene cause

Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia

✍ Delphine Allard; Sabine Amsellem; Marianne Abifadel; Mélanie Trillard; Martine D 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Autosomal dominant hypercholesterolemia (ADH) is a frequent (1/500) monogenic inherited disorder characterized by isolated elevation of LDL leading to premature cardiovascular disease. ADH is known to result from mutations at two main loci: LDLR (encoding the low density lipoprotein receptor), and A

Mutations of the EPHA2 receptor tyrosine

Mutations of the EPHA2 receptor tyrosine kinase gene cause autosomal dominant congenital cataract

✍ Tianxiao Zhang; Rui Hua; Wei Xiao; Kathryn P. Burdon; Shomi S. Bhattacharya; Jam 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Congenital cataracts (CCs) are clinically and genetically heterogeneous. Mutations in the same gene may lead to CCs differing in inheritance, morphology and severity. Loci for autosomal dominant posterior polar CC and total CC have both been mapped to the chromosomal 1p36 region harboring the EPHA2

Clinical variability of autosomal domina

Clinical variability of autosomal dominant cataract, microcornea and corneal opacity and novel mutation in the alpha A crystallin gene (CRYAA)

✍ Leslie Richter; Pamela Flodman; Fernando Barria von-Bischhoffshausen; Douglas Bu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

Three novel mutations of the PKD1 gene i

Three novel mutations of the PKD1 gene in Italian families with autosomal dominant polycystic kidney disease

✍ Alberto E. Turco; Sandro Rossetti; Elena Bresin; Sabine Englisch; Stefano Corrà; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

Four novel mutations of the PKD2 gene in

Four novel mutations of the PKD2 gene in czech families with autosomal dominant polycystic kidney disease

✍ J. Reiterová; J. Štekrová; D.J.M. Peters; J. Kapras; M. Kohoutová; M. Merta; J. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Communicated by Mark H. Paalman Autosomal dominant polycystic kidney disease (ADPKD) is a genetically heterogeneous disease caused by mutations in at least three different loci. Mutations in the PKD2 gene are responsible for approximately 15% of the cases of the disease. We have screened 14 Cze

Clinical phenotype of autosomal dominant

Clinical phenotype of autosomal dominant progressive external ophthalmoplegia in a family with a novel mutation in the C10orf2 gene

✍ Daojun Hong; Hongyan Bi; Sheng Yao; Zhaoxia Wang; Yun Yuan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

## Abstract Autosomal dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder caused by mutations in nuclear genes. Here we report the clinical and genetic features of adPEO in a Chinese family. All patients had gradual onset of ptosis, with or without ophthalmoplegia, aro